Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Lung Cancer treatment details. Chemotherapy. National Cancer Center Hospital East, Chiba, Japan

Survival: 11.1 months
Toxicity Grade: 4
Treatments: Chemotherapy
Drugs: Gemzar
Country: Japan
City/State/Province: Chiba
Hospital: National Cancer Center Hospital East
Journal: Link
Date: 7/2003

Patients: This Phase I/II trial involved 29 patients with recurrent non-small-cell lung cancer. The majority of patients had adenocarcinoma and were stage IV.

Treatment: The treatment consisted of two drugs, gemcitabine (gemzar) and docetaxel (taxotere).

Toxicity: Grade 4 toxicities included leucopenia and neutropenia. Other toxicities included anemia, thrombocytopenia, nausea, vomiting/diarrhea, infection, , neutropenic fever, rash, neurotoxicity, fever (no infection), AST, ALT, serum creatinine, and hyponatremia.

Results: Median survival was 11.1 months.

Correspondence: S. Niho, MD

E-mail to a Friend Email Physician More Information